Cytarabine lung toxicity
WebSevere and at times fatal CNS, GI and pulmonary toxicity (different from that seen with conventional therapy regimens of cytarabine injection) has been reported following some experimental dose schedules for … WebAdverse effects from high-dose cytarabine (2-3 g/m 2) include severe and occasionally fatal CNS, cardiovascular, gastrointestinal or pulmonary toxicity, as well as corneal toxicity or conjunctivitis (may be hemorrhagic). Ocular toxicity is minimized by prophylactic use of ophthalmic corticosteroids.
Cytarabine lung toxicity
Did you know?
WebCytarabine, also known as cytosine arabinoside (ara-C), is a chemotherapy medication used to treat acute myeloid leukemia (AML), ... When used in protocols designated as high dose, cytarabine can cause cerebral and cerebellar dysfunction, ocular toxicity, pulmonary toxicity, ... WebCytosine arabinoside (also known as cytarabine or Ara-C) has been combined with TBI or other chemotherapies for conditioning. 13 CNS toxicity is dose-related and is the dose limiting toxicity of cytarabine. 18 In patients receiving high-dose cytarabine, the incidence of neurotoxicity is approximately 10%. 19 Cerebellar dysfunction is the most ...
WebNational Center for Biotechnology Information
WebThe only significant toxicity of low-dose cytarabine is myelosuppression. Given the generally poor condition of leukaemia patients, low-dose cytarabine therapy is well … http://www.haematologica.org/content/92/9/e85#:~:text=Abstract.%20Potentially%20fatal%20lung%20toxicity%20occurs%20in%2012%E2%80%9320%25,bronchiolitis%20obliterans%20organizing%20pneumonia%20%28BOOP%29%20has%20been%20reported.
WebNov 23, 2024 · Side effects include: IV, sub-Q, or IM administration of conventional cytarabine: Myelosuppression, anorexia, nausea, vomiting, diarrhea, oral and anal …
WebDec 1, 2011 · Cytarabine-induced toxicity, probably related to a cytokine-mediated mechanism, is an under-recognized etiology of respiratory symptoms and lung infiltrates, … how to see past attachments in outlookWebExperimental Doses: Severe and at times fatal CNS, GI and pulmonary toxicity (different from that seen with conventional therapy regimens of cytarabine) has been reported following some experimental dose schedules of cytarabine. These reactions include reversible corneal toxicity and hemorrhagic conjunctivitis, which may be prevented or ... how to see past amber alerts on androidhttp://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Cytarabine_monograph_1May2014.pdf how to see past emailsWebSevere and at times fatal CNS, GI and pulmonary toxicity (different from that seen with conventional therapy regimens of cytarabine) has been reported following some … how to see past dms on discordWebpalifermin increases toxicity of cytarabine by Other (see comment). Avoid or Use Alternate Drug. Comment: Palifermin should not be administered within 24 hrbefore, during infusion of, or within 24 hr after administration of antineoplastic agents. ... GI, and pulmonary toxicity. Cardiomyopathy with subsequent death reported following ... how to see past faceit matchesWebCentral nervous system disturbances, especially impaired cerebellar function, limit doses of cytarabine, and age is an important predictive factor. Of 418 patients who received … how to see past epic games usernamesWebRespiratory Pulmonary toxicity in the form of non-cardiogenic pulmonary edema has been reported in 12–20% of patients with leukemia treated with high-dose cytarabine; it is potentially fatal. It occurs at a median of 1–2 weeks after the start of therapy and is thought to be a cytokine-mediated event, resulting in alveolar damage and ... how to see past auctions on ebay